NeoGenesis Co., Ltd.

CEO : Yongpil Kim

As an enterprise specializing in autologous cell therapy, NeoGenesis develops and exports medical devices to the global market.-Since our foundation in 2012, we at NeoGenesis have strived to research and develop innovative medical devices. With expertise in the autologous cell therapy field, we provide our medical devices to not only the domestic market, but also to the global market including the Americas, Europe, Asia, and Africa.-We have made efforts to supply knowledge of modern cell therapy through participation in seminars, exhibitions, and training around the world, and now contribute to the global beauty industry as well.-NeoGenesis will continue to provide safety and quality guaranteed medical devices and pharmaceuticals, striving for the convenience, satisfaction, and trust that our users and patients rightfully deserve.